Gilead signs agreements with 6 generic manufacturers for Lenacapavir The generic companies that will manufacture and supply Lenacapavir to 120 countries are Dr. Reddy’s, Emcure, Eva Pharma, Ferozsons Laboratories, Hetero and Mylan, a subsidiary of Viatris CVS Health laying off more than 400 Aetna employees Of the total of 416 impacted positions, 93 are held by Connecticut residents. Family Heart Foundation partners with health systems on heart disease screening This program utilizes a machine-learning model to identify people who are likely to have elevated Lp(a). Surescripts partners with TPG TPG, a global alternative asset management firm, will join the Surescripts ownership group as a majority investor. Teva intros generic Sandostatin LAR Depot Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome. Kroger closes sale of specialty pharmacy business Kroger finalized its specialty pharmacy business sale to Elevance Health. Walgreens taps Jason Stenta as SVP, chief commercial officer In this role, Stenta will lead the company’s commercial growth strategy. Dr. Reddy’s completes acquisition of Haleon’s Nicotinell The acquired portfolio includes Nicotinell, also known as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada. Walmart expands Cancer Centers of Excellence program for associates A collaboration with the Mayo Clinic, the center provides associates access to top cancer specialists. Fresenius Kabi, Formycon receive FDA nod for Stelara biosimilar Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. First Previous 28 29 30 31 32 Next Last
